Dr Judith Dunn

Vice President, Global Head of Clinical Development Roche Innovation Center

Dr Judith Dunn is a member of Roche’s pharma Research and Early Development (pRED) Leadership Team, focused on the discovery and early development of new medications that significantly improve the lives of patients and their families. As Vice President of Clinical Development, Judy leads several functions which contribute to the design and execution of clinical programs across all therapeutic areas in the pRED portfolio (Immunology and Inflammation, Infectious Diseases, Neuroscience, Oncology, Ophthalmology, and Rare Diseases) from Entry into Human to Proof of Concept.  Additionally, Judy is the head of the Roche Innovation Center, NYC. Judy has more than 25 years of international experience in the pharmaceutical industry.  She began her career as a discovery scientist in biotech, held positions in both the research and Commercial divisions of Pfizer, and led Psychiatry Clinical Development efforts at Sepracor, a specialty pharma company.  Judy attended Wesleyan University and the University of Rochester, obtaining undergraduate and graduate degrees in Neurobiology. She was the recipient of a Research Fellowship in Neuropharmacology from the Center for Brain Research at Strong Memorial Hospital, as well as a Postdoctoral Fellowship in Clinical Research from Pfizer. Judy is an active member of the NYC life sciences community where she works to promote collaboration and growth. Judy is a board member of NewYorkBIO and the Partnership for New York City.